• OPEN AN ACCOUNT
Indian Indices
Nifty
25,461.00 55.70
(0.22%)
Sensex
83,432.89 193.42
( 0.23%)
Bank Nifty
57,031.90 239.95
( 0.42%)
Nifty IT
39,166.55 312.25
( 0.80%)
Global Indices
Nasdaq
44,849.54 344.11
(0.77%)
Dow Jones
6,300.35 51.93
(0.83%)
Hang Seng
39,792.23 6.33
(0.02%)
Nikkei 225
8,822.91 -0.29
(0.00%)
Forex
USD-INR
85.44 -0.20
(-0.23%)
EUR-INR
100.61 -0.32
(-0.32%)
GBP-INR
116.59 -0.52
(-0.45%)
JPY-INR
0.59 0.00
(-0.64%)

EQUITY - MARKET SCREENER

Remus Pharmaceuticals Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
78788
INE0O5T01011
205.5515954
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
REMUS
56.5
1124.49
EPS(TTM)
Face Value()
Div & Yield %
16.89
10
0
 

ARCL Organics Ltd - Board Meeting Intimation for Audited Standalone And Consolidated Financial Results Of The Company For The Quarter And Financial Year Ended On 31St March 2025.
May 06,2025
ARCL Organics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/05/2025 inter alia to consider and approve Audited Standalone and Consolidated Financial Results of the Company for the quarter and financial year ended on 31st March 2025.